WO2009063081A3 - Composition comprising at least one nucleosidic moiety as a therapeutic agent, and ckc. - Google Patents
Composition comprising at least one nucleosidic moiety as a therapeutic agent, and ckc. Download PDFInfo
- Publication number
- WO2009063081A3 WO2009063081A3 PCT/EP2008/065618 EP2008065618W WO2009063081A3 WO 2009063081 A3 WO2009063081 A3 WO 2009063081A3 EP 2008065618 W EP2008065618 W EP 2008065618W WO 2009063081 A3 WO2009063081 A3 WO 2009063081A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- composition
- ckc
- therapeutic agent
- nucleosidic moiety
- nucleosidic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Ophthalmology & Optometry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Composition comprising at least one nucleosidic moiety and cetalkonium chloride and pharmaceutical use thereof for prevention, treatment or relief of eye, lung, and/or respiratory tract conditions.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/939,840 US7834172B2 (en) | 2007-11-14 | 2007-11-14 | Composition comprising at least one nucleosidic moiety as a therapeutic agent, and CKC |
EP07301550.5 | 2007-11-14 | ||
EP07301550A EP2060262B1 (en) | 2007-11-14 | 2007-11-14 | Composition comprising at least one nucleosidic moiety as a therapeutic agent, and ckc |
US11/939,840 | 2007-11-14 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2009063081A2 WO2009063081A2 (en) | 2009-05-22 |
WO2009063081A3 true WO2009063081A3 (en) | 2009-09-24 |
Family
ID=40639235
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2008/065618 WO2009063081A2 (en) | 2007-11-14 | 2008-11-14 | Composition comprising at least one nucleosidic moiety as a therapeutic agent, and ckc. |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2009063081A2 (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050096287A1 (en) * | 1998-05-21 | 2005-05-05 | Mehta Rahul C. | Compositions and methods for topical delivery of oligonucleotides |
EP1655021A1 (en) * | 2004-11-09 | 2006-05-10 | Novagali Pharma SA | Oil-in-water type emulsion with low concentration of cationic agent and positive zeta potential |
WO2006060723A2 (en) * | 2004-12-03 | 2006-06-08 | Vical Incorporated | Methods for producing block copolymer/amphiphilic particles |
EP1891939A1 (en) * | 2006-07-28 | 2008-02-27 | Novagali Pharma SA | Compositions containing quaternary ammonium compounds |
-
2008
- 2008-11-14 WO PCT/EP2008/065618 patent/WO2009063081A2/en active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050096287A1 (en) * | 1998-05-21 | 2005-05-05 | Mehta Rahul C. | Compositions and methods for topical delivery of oligonucleotides |
EP1655021A1 (en) * | 2004-11-09 | 2006-05-10 | Novagali Pharma SA | Oil-in-water type emulsion with low concentration of cationic agent and positive zeta potential |
WO2006060723A2 (en) * | 2004-12-03 | 2006-06-08 | Vical Incorporated | Methods for producing block copolymer/amphiphilic particles |
EP1891939A1 (en) * | 2006-07-28 | 2008-02-27 | Novagali Pharma SA | Compositions containing quaternary ammonium compounds |
Non-Patent Citations (1)
Title |
---|
EVANS ROBERT K ET AL: "Characterization and biological evaluation of a microparticle adjuvant formulation for plasmid DNA vaccines.", JOURNAL OF PHARMACEUTICAL SCIENCES JUL 2004, vol. 93, no. 7, July 2004 (2004-07-01), pages 1924 - 1939, XP002539854, ISSN: 0022-3549 * |
Also Published As
Publication number | Publication date |
---|---|
WO2009063081A2 (en) | 2009-05-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL205320A0 (en) | Compositions comprising an electrochemically altered fluid and a therapeutic agent and use thereof for treating lung or respiratory diseases | |
HK1129594A1 (en) | Use of substituted 2-aminotetralines for the manufacture of a medicament for the prevention, alleviation and/or treatment of various types of pain | |
SG150531A1 (en) | Use of meloxicam for the treatment of respiratory diseases in pigs | |
WO2008041003A3 (en) | Hydroxycholesterols and its prodrugs for the treatment of insulin resistance and disorers asociated therewith | |
ZA200703601B (en) | Medicaments for the treatment or prevention of fibriotic diseases | |
IL180565A0 (en) | An improved stopcock for administering medicaments into the patient's body | |
WO2010014690A3 (en) | Medical devices for therapeutic agent delivery | |
IL221795B (en) | Use of a pharmaceutical composition of methylnaltrexone, or a salt thereof, in the preparation of a medicament for treating the side effects of opioid treatment | |
WO2007146426A3 (en) | Nanoshells for drug delivery | |
EP2671584A3 (en) | Compositions and methods for treating disorders associated with salt or fluid retention | |
WO2006099541A3 (en) | Therapeutic wound care product | |
WO2008128740A8 (en) | Titration of tapentadol | |
BRPI0806392A8 (en) | use of aclidinium, aclidinium, treatment or prevention method and pharmaceutical composition | |
WO2011014255A8 (en) | Treatment of crohn's disease with laquinimod | |
WO2009008001A3 (en) | Inhalation device | |
IL206296A (en) | Aminopyrazole derivatives, pharmaceutical compositions comprising them and their use in the manufacture of medicaments for prevention or treatment of diseases | |
IL228904A0 (en) | Use of milnacipran, or a pharmaceutically acceptable salt thereof, in the preparation of a medicament for treating fibromyalgia | |
MX2009004561A (en) | Pyrazolyl derivatives with analgesic activity and therefore useful in the treatment or prophylaxis of pain. | |
WO2007138466A3 (en) | Pharmaceutical compositions comprising meloxicam and tramadol combination | |
MX2009011900A (en) | Diabetic wound healing. | |
WO2008016640A3 (en) | Use of poloxamer for the prevention and/or treatment of heart failure | |
WO2005082413A3 (en) | Ciclesonide and glycopyrronium combination | |
WO2008070010A3 (en) | Hydroxylamine derivatives for the treatment of stroke | |
PL1610787T3 (en) | Synergistic combination comprising roflumilast and an anticholinergic agent selected from tiotropium salts for the treatment of respiratory diseases | |
MXPA05010161A (en) | Synergistic combination comprising roflumilast and an anticholinergic agent selected from ipratropium, oxitropium and tiotropium salts for the treatment of respiratory diseases. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 08849479 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 08849479 Country of ref document: EP Kind code of ref document: A2 |